Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
HOW IS IT POSSIBLE THE JUDGE HAS NOT RULED YET????????
SOMETHING SMELLS
what happened in premarket?
UPDATE 1-RESEARCH ALERT-Stifel starts Aastrom with buy; shares jump
Published: Monday, 28 Mar 2011 | 11:18 AM ET Text Size
Twitter LinkedInMore Share
* Stifel cites company technology for rating * Sets price target at $4.50 * Shares up as much as 17 percent March 28 (Reuters) - Stifel Nicolaus initiated coverage of Aastrom Biosciences Inc with a "buy" rating, saying the company is well-positioned to become one of the first to have a cell-based therapy for a degenerative condition approved by the U.S. health regulator. Shares of the stem cell research company jumped as much as 17 percent in morning trade to touch a high of $2.58. Aastrom is developing an experimental treatment for a blood vessel condition that delivers the patient's own bone marrow directly to the damaged tissues. The technology is called tissue repair cell technology. "We believe a limited competitive landscape and substantial pricing flexibility should translate into more than $1 billion in sales if approved," said analyst Stephen Willey, who set a price target of $4.50 on the stock. The treatment is set to be tested in a late-stage study this year, the design for which is agreed upon by the U.S. Food and Drug Administration and the Ann Arbor, Michigan-based company. Aastrom shares, which have lost about 18 percent since the company gave results from its second mid-stage study in mid-November, were trading up 13 percent at $2.50 on Nasdaq. Keywords: AASTROMBIOSCIENCES/RESEARCH STIFEL XX:SU:REUTERS#SN:nL3E7ES2O7#XX:606440.0#HS:RAMSTXT_0_2011-3-28_150349_1_86#DU:rexwire+reewire+reawire+bsu8rtr+bsu8rtr+lanreunxd1#XN:##XP:tfukfipdista.datastream.com ~ (Reporting by Vidya L Nathan; Editing by Jarshad Kakkrakandy)(vidya.loganathan@thomsonreuters.com)(+1 646 223 8780)(vidya.loganathan.thomsonreuters.com@reuters.net) COPYRIGHT Copyright Thomson Reuters 2011. All rights reserved.
The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
any court updating by call to clerk?
thanks in advanced
SOMEONE POSTED AT YAHOO MESSAGE BOARD THAT PROBABLY A JUDGE RULE HAS BEEN DEPOSIT AS ALL FILES HAS BEEN DELATED ON CASE PAGE.
PLEASE COULD YOU CHECK IF THAT'S TURE?
OR PLEASE COULD YOU CALL THE COURT AS I AM EUROPEAN.
THANKS
thanks so much Sun!
thnak you very much for the updating present and future.
Really very appreciated since no official or unofficial comments on that issue form both parties.
VOTE YES; OTHERWISE YOUR INVESTMENT IS GONE FOREVER!
ARE YOU SO NO-BRAINER TO LISTEN THOSE WHO SUGGET YOU TO VOTE AGAINST CBAI FUTURE???????????
THAT'S YOUR CHOICE BUT STILL I'M GOING TO PROTECT MY INVESTMENT GIVING FUEL TO PROCEED WITH THE ONGOING OPERATIONS
new 8-K Sec filing; that's the reason why it is so important to approve R/S and A/S; otherwise our investment is gone!
Do not listen those who suggest you to vote against proposal; they are not invested and they are paid to make CBAI broken on convincing you to vote against
If you vote NO you have lost your money invested, wihout any other possibility to recover partially or totally (it depends on your pps); are you happy then???
Just my opinion
we are very much grateful and we thank your wife and you for such a great info
all the best for 2011!
thanks for your kindly effort to share with us RTQ Very appreciated
PLEASE SELL ME YOUR SHARES AND BRING PPS BELOW 0,004!!!
I'LL BUY ALL OF YOURS SHARES.
DEW THIS ACQUISITION IS THE APPROPRIATE SIZE I EXPECTED TO BE ANNOUNCED BY CHRISTMAS.
FOR OUR TREASURY A 18 ML USD DEAL IS THE MAXIMUM EFFORT WE CAN SUSTAIN FINANCIALLY RIGHT NOW.
14 ML USD ARE ALREADY AT OUR DISPOSAL AS CREDIT LINE FOR ACQUISITION AS ANNOUNCED BY CBAI AT THE BEGINNING OF THIS YEAR (THESE CREDIT LINES WERE AVAIABLE FOR 16 ML USD MINUS 2 MLS FOR BIOCORDCELL S.A. = 14 ML USD YET AT OUR DISPOSAL)
I FIND STRANGE IT WAS MENTIONED CBAI NEEDED TO FUND RAISE PRIVATELY 14 ML USD AS THEY ANNOUNCED THE ABOVE MENTIONED CREDIT LINES FOR ONLU ACQUISITION PURPOSES AT THE BEGINNING OF THE YEAR AND NO OTHER EVENT OCCURED EXCEPTF FOR BIOCORDCELL S.A. ACQUISITION
ALL THAT SAID, THIS IS THE KNOCK ME OVER THE FEATHER IT WAS EXPECTED TO BE ANNOUNCED BY CHIRSTMAS; AND PROBABLY IT IS A KNOCK ME OVER THE FEATHER OF ANOTHER BIGGER TARGET...
14 ml usd are already at our disposal as credit line for acquisitions. read old 8-k filings beginning of 2010...
WE (DEW AND ME) TOLD YOU GYS... NOW LET'S BUY SHARES AT HIGHER PRICE...CONGRATULATIONS!!!!
HERE ANOTHER CLEAR PROVE ON WHAT WILL HAPPEN TO ASTM
http://www.businessspectator.com.au/bs.nsf/Article/UPDATE-1-Cephalon-Mesoblast-in-stem-cell-developme-BX2K4?opendocument&src=rss
AFTER CEPHALON-MESOBLAST DEAL, A NEW TREND AMONG BIG PHARMA-ADUL STEM CELL CO WILL REVAMP!!!
http://finance.yahoo.com/news/Cephalon-and-Mesoblast-Enter-prnews-1094750490.html?x=0&.v=1
NEXT OUR TURN....
THANKS FOR YOUR SHARES. ACCUMULATION IS OCCURING AT THESE PRICE
NOT CHEAP; HOWEVER A BIG SPIKE IT HAS HAPPENED IN 3 OF 4 LAST END OF YEARS (CROSSING THE NEW)
IT WILL HAPPEN AGAIN THIS TIME.
NOT BECAUSE OF FUNDAMENTALS; NOT BECAUSE OF FLUFF PR; NOT BECASUE OF MATT; NOT BECASUE OF FUTURE PLANS.
BECAUSE IT IS A PENNY STOCK AND MM PLAY ALL THE TIME IN THE SAME PATTERN (OR ALMOST ALL THE TIME).
HOPE WILL NOT CHANGE THEIR PLAYING THIS TIME...
0,004 FLOOR SEEMS TO BE PRETTY STRONG AND USEFUL FOR ANOTHER SPIKE IN THE HIGHS 8'S OR 9'S SUB PENNIES. PROPRBALY PENNY LAND WILL BE REACH FOR FEW HOURS....
GOOD LUCK TO ALL BELIEVERS OR TO THOSE WHO WILL SHORT AGAIN IN THE COMING DAYS...
i'm still averaging down as much as i can. Even in these days because i like matt and his daily effort very very much. 9,500,000 milions shares on my pocket. however, i'm losing some confidence. Hope to be rewarded by year end by a substantial (and not fluffy) pr
DEW
I HAVE ALWAYS APPRECIATED YOUR POSTS. I AGREE WITH YOU CONFIDENCE BECASUE I HAVE MET ONCE HERE IN EUROPE.
I FOUND HIM AN INSPIRED ENTREPRENUER, ABSOLUTELY INVOLVED IN WHAT HE IS DOING.
I AM SURE HE WILL BE A WINNER OR A LOSER IN LIFE ACCORDING TO CBAI DESTINY.
HOWEVER I'M LITTLE SCARED WE WILL GET NOT PROFITABILITY IN A SHORT TIME WITHOUT THE KNOCK ME OVER THE FEATHER MOVE. AND IT SEEMS THIS MOVE WILL NEVER HAPPEN IN THE SHORT RUN DESPITE OUR DREAMS OR HOPES. AND WHAT MAKES THINGS WORSE IT SEEMS WE ARE DILUTING TOO MUCH WITHOUTH GETTING PROFITABILITY BEFORE ENDING THE PRINTING OF AUTHORIZED SHARES
HAVE YOU A DIFFERENT OPINION?
THANKS
wellpoint pays for hematopoietic stem cell transplant - medical policy effective date 11/18/2010
http://scmedpolicies.wellpoint.com/medicalpolicies/policies/mp_pw_a047489.htm
this new medical policy changes all things for ucb banking in the years ahead...and pretty dramatically...
CCEL.OB rejects an unsollicited offer from a Private Equity Fund
http://finance.yahoo.com/news/CryoCell-International-pz-2178062865.html?x=0&.v=1
Finally, something is brewing in the sector, after VIAC/PKI deal in october 2007.